By Assaf Halevy
2018 has been a year of acceleration for organizations seeking to leverage precision medicine. Momentum is clearly building as healthcare leaders explore how genomics could impact real-time clinical decision-making.
This puts the industry on the brink of what Malcolm Gladwell famously characterized as a tipping point: that moment when an idea or innovation “crosses a threshold…and spreads like wildfire.”
While preparing for a genomics “wildfire” might be overly optimistic, there is little doubt that 2019 will fuel significant progress in converting the promise of precision medicine into daily clinical practice.[Read more…]